Only 22 compensated in four years, admits drugs controller during RTI hearing As many as 2,031 people in India have died because of the clinical drug trials they were subjected to in the past four years. Only 22 of them have been compensated. What's more, no action has been taken so far against any pharma company, ethics committee that oversees clinical trials or contract research organisation that conducts the trials, which...
More »SEARCH RESULT
Indian police still using truth serum-Helen Pidd
-The Guardian Use of Sodium Pentothal to secure confessions – classified by some as torture – still common in certain regions of India It is the sort of scene that belongs in a film noir, not a 21st-century democracy: an uncooperative suspect being injected with a dose of "truth serum" in an attempt to elicit a confession. But some detectives in India still swear by so-called narcoanalysis despite India's highest court ruling...
More »Public health crisis-R Ramachandran
The goal of universal health care requires an overhaul of the public health system, medical education and regulatory mechanisms. At long last, public health is on the agenda of the country’s policy makers. The Prime Minister’s Republic Day speech mentioned that the Twelfth Plan would focus on health just as the Eleventh Plan had focussed on education. But the manner in which the education sector has been messed with does not...
More »Hit by red tape, clinical trial companies eye South-East Asia for expansion-Divya Rajagopal
-The Economic Times Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities. Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...
More »Early insulin intake may prevent diabetes, but not heart disorders: Study by Pushpa Narayan
Does long-term intake of a special form of insulin prevent diabetes and heart problems, but cause cancer? The debate has been raging in medical circles for long. Now, an international study involving 12,000 pre-diabetics settles two parts of it, but leaves the other open for further research. Results of ORIGIN (Outcome Reduction with Initial Glargine Intervention) study presented in the wee hours of Tuesday at the annual meeting of the American...
More »